Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

Exclusion Criteria

• •Use of any other investigational or non-registered drug or vaccine in addition to the study vaccine during the study period or within 30 days preceding the first dose of study vaccine
• •History of any previous JE vaccination (e.g. JE-VAX®)
• •Immunodeficiency including post-organ-transplantation or immunosuppressive therapy
• •A family history of congenital or hereditary immunodeficiency
• •History of autoimmune disease
• •Any acute infections within 2 weeks prior to enrollment
• •Known or suspected HIV Infection
• •Pregnancy, lactation or unreliable contraception in female subjects